In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ImmusanT, Inc.

http://www.immusant.com/

Latest From ImmusanT, Inc.

Tasso Launches At-Home Blood Draw Platform For Trial Pre-Screening

Tasso has launched Tasso Care, a “scalable” blood data collection platform built around its unique at-home blood collection kit and screening data system.

Clinical Trials Business Strategies

No, I Am Spartacus – Embecta Joins The Quell Against GLP-1 Hype

Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned. 

Diabetic Care Drug Delivery Technology

The E In ESG: How To Factor In Sustainability Costs

The 2023 LSX Congress in Boston, MA, heard the views of top-tier medtechs BD, GE HealthCare and Merit Medical as they outlined sustainability compliance strategies and goal setting mechanisms, as summarized in this latest contribution to In Vivo’s rolling series on “The E in ESG.”

Leadership Sustainability

Medtronic Hires New Neuromodulation Leader

Paolo Di Vincenzo, the general manager of Smith+Nephew's US advanced wound management business will join Medtronic as the president of its neuromodulation business.

Executive Changes Neurology
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
UsernamePublicRestriction

Register